Clinical Trial Update: A Study of the Efficacy of Genakumab in Prevention of Acute Flares in Gout Patients Initiating Urate-lowering TherapyUrate-lowering (GenSci048-202) [Phase 2]

View source ↗

Summary

A completed Phase 2 trial evaluating the efficacy of Genakumab to prevent acute gout flares in patients initiating urate-lowering therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Genakumab

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Gout, Gout Initiating Urate-loweringUrate-lowering Therapy | Phase 2 | Status: COMPLETED